|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $2 and $11, respectively | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Deferred financing costs | ||||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| NONCURRENT ASSETS | ||||||||||||||||||||
| Right-of-use and financing lease assets, net | ||||||||||||||||||||
| Right-of-use operating and financing lease assets, net | ||||||||||||||||||||
| Machinery and equipment, net, and construction in progress | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Restricted cash, noncurrent | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Due to related party (Note 9) | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued royalties | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Right-of-use liabilities, current | ||||||||||||||||||||
| Accrued severance from acquisition | ||||||||||||||||||||
| Right-of-use and financing lease liabilities, current | ||||||||||||||||||||
| Current liabilities of discontinued operations (Note 13) | ||||||||||||||||||||
| Operating and financing lease liabilities, current | ||||||||||||||||||||
| Contingent consideration liabilities, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| NONCURRENT LIABILITIES | ||||||||||||||||||||
| Right-of-use and financing lease liabilities, noncurrent | ||||||||||||||||||||
| Operating and financing lease liabilities, noncurrent | ||||||||||||||||||||
| Contingent consideration liabilities, noncurrent | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Series A Redeemable Convertible Preferred Stock, no par value; stated value $1,000 per share; 5 shares issued and outstanding at December 31, 2023; aggregate liquidation preference of $5,296 as of December 31, 2023 | ||||||||||||||||||||
| Total series A Redeemable Convertible Preferred Stock, no par value; stated value $1,000 per share; 5 shares issued and outstanding at December 31, 2023; aggregate liquidation preference of $5,296 as of December 31, 2023 | ||||||||||||||||||||
| SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
| Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, no par value, 230,000 shares authorized; 32,623 and 28,683 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
